Search Results for: Boehringer
Boehringer agrees new partnership to advance first-in-class precision cancer therapies
2025-04-24
South Korea’s Olix Strikes $660M Deal with Eli Lilly for Phase 1 MASH candidate
2025-02-11
Neuro, Pain, and Cancer Top the List at JPM 2025 Healthcare Conference
2025-01-17
Pre-JPM 2025: The Quiet Deals You May Have Missed Before the Big Show
2025-01-16
A Look at 2024’s Patent Expirations and Generic Competition
2024-12-31
Insilico Medicine Reports Breakthrough Phase IIa Results for AI-Driven IPF Drug ISM001-055
2024-11-19
CDMO Samsung Bio Secures Record $1.24 Billion Biopharma Manufacturing Contract, Raising Total 2024 Deal Value to Over $3.3 Billion
2024-10-23
Can New GLP-1 Contenders Disrupt the Weight-Loss Giants, Lilly and Novo, in the Battle for Market Dominance?
2024-10-03
Cost Cuts for 10 Medicare Part D Drugs: Billions Still to Be Made
2024-08-20
NMT Inhibitors and Next-Gen Nectin-4 ADCs a Field Ripe for Research – Part II
2024-08-01
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
JPM 2024: AZ, Ginkgo and Moderna Provides Business Updates, Illustrating Optimistic Prospects
2024-01-11
PRISM BioLab and Eli Lilly Join Forces in Revolutionary Drug Discovery Collaboration
2023-12-05
Japan’s Red Biotechnology and International Business Partnering Take Spotlight on BioJapan 2023
2023-11-03
Angelini Pledges Over $500 Million in Biobucks for JCR’s Epilepsy Therapy Tech
2023-05-11
1 2 3 4
Scroll to Top